White Paper

5 ADC Manufacturing Challenges You Need To Know

5 ADC Manufacturing Challenges You Need To Know

The unique targeting capabilities and encouraging clinical trial results of antibody drug conjugates (ADCs) have made them an exciting and promising treatment in the fight against cancer. According to recent analysis, experts anticipate the ADC market to be worth $10 billion annually by 2025. Drug makers face a number of challenges in the manufacturing process for ADCs. Here we provide you with five key areas where pharmaceutical manufacturers may face the biggest uphill battles.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

Ajinomoto Bio-Pharma Services